[1] Mizuno H, Zuk PA, Zhu M, et al. Myogenic differentiation by human processed lipoaspirate cells. Plast Reconstr Surg. 2002;109(1):199-209.[2] Antonitsis P, Ioannidou-Papagiannaki E, Kaidoglou A, et al. In vitro cardiomyogenic differentiation of adult human bone marrow mesenchymal stem cells. The role of 5-azacytidine. Interact Cardiovasc Thorac Surg. 2007;6(5):593-597.[3] Apdik H, Do?an A, Demirci S, et al. Dose-dependent Effect of Boric Acid on Myogenic Differentiation of Human Adipose-derived Stem Cells (hADSCs). Biol Trace Elem Res. 2015;165(2):123-130.[4] Bayati V, Sadeghi Y, Shokrgozar MA, et al. The evaluation of cyclic uniaxial strain on myogenic differentiation of adipose-derived stem cells. Tissue Cell. 2011;43(6):359-366.[5] Stern-Straeter J, Bonaterra GA, Juritz S, et al. Evaluation of the effects of different culture media on the myogenic differentiation potential of adipose tissue- or bone marrow-derived human mesenchymal stem cells. Int J Mol Med. 2014;33(1):160-170.[6] Lee EM, Kim AY, Lee EJ, et al. Therapeutic effects of mouse adipose-derived stem cells and losartan in the skeletal muscle of injured mdx mice. Cell Transplant. 2015;24(5):939-53.[7] Vieira NM, Brandalise V, Zucconi E, et al. Human multipotent adipose-derived stem cells restore dystrophin expression of Duchenne skeletal-muscle cells in vitro. Biol Cell. 2008; 100(4):231-241.[8] 陈犹白,陈聪慧,Qixu Zhang,等.脂肪干细胞表型和标记物的研究进展[J].中国美容医学,2016,25(3):91-100.[9] Montarras D, Chelly J, Bober E, et al. Developmental patterns in the expression of Myf5, MyoD, myogenin, and MRF4 during myogenesis. New Biol. 1991;3(6):592-600.[10] Sung MS, Mun JY, Kwon O, et al. Efficient myogenic differentiation of human adipose-derived stem cells by the transduction of engineered MyoD protein. Biochem Biophys Res Commun. 2013;437(1):156-161.[11] Schenborn ET, Berg LD. Enhanced expression of transfected genes by MyoD. Molecular Biology of the Cell. 2000; 11:14A-15A.[12] Kim MH, Hong HN, Hong JP, et al. The effect of VEGF on the myogenic differentiation of adipose tissue derived stem cells within thermosensitive hydrogel matrices. Biomaterials. 2010; 31(6):1213-1218.[13] 陈犹白,张启旭, Butler CE,等.DOTAP脂质体介导VEGF基因转染人脂肪干细胞及目的基因的表达[J].临床耳鼻咽喉头颈外科, 2016,30(12):966-971.[14] Sumino Y, Hanada M, Hirata Y, et al. The effects of hepatocyte growth factor and insulin-like growth factor-1 on the myogenic differentiation of satellite cells in human urethral rhabdosphincter. Neurourol Urodyn. 2010; 29(3): 470-475.[15] Prelle K, Wobus AM, Krebs O, et al. Overexpression of insulin-like growth factor-II in mouse embryonic stem cells promotes myogenic differentiation. Biochem Biophys Res Commun. 2000;277(3):631-638.[16] Bourlier V, Sengenès C, Zakaroff-Girard A, et al. TGFbeta family members are key mediators in the induction of myofibroblast phenotype of human adipose tissue progenitor cells by macrophages. PLoS One. 2012;7(2): e31274.[17] Kawai T, Takahashi T, Esaki M, et al. Efficient cardiomyogenic differentiation of embryonic stem cell by fibroblast growth factor 2 and bone morphogenetic protein 2. Circ J. 2004;68(7):691-702.[18] Shi S, Hoogaars WM, de Gorter DJ, et al. BMP antagonists enhance myogenic differentiation and ameliorate the dystrophic phenotype in a DMD mouse model. Neurobiol Dis. 2011;41(2):353-360.[19] Diao Y, Wang X, Wu Z. SOCS1, SOCS3, and PIAS1 promote myogenic differentiation by inhibiting the leukemia inhibitory factor-induced JAK1/STAT1/STAT3 pathway. Mol Cell Biol. 2009;29(18):5084-5093.[20] Winbanks CE, Wang B, Beyer C, et al. TGF-beta regulates miR-206 and miR-29 to control myogenic differentiation through regulation of HDAC4. J Biol Chem. 2011;286(16): 13805-13814. [21] Zhang J, Ying ZZ, Tang ZL, et al. MicroRNA-148a promotes myogenic differentiation by targeting the ROCK1 gene. J Biol Chem. 2012;287(25):21093-21101.[22] Nakajima N, Takahashi T, Kitamura R, et al. MicroRNA-1 facilitates skeletal myogenic differentiation without affecting osteoblastic and adipogenic differentiation. Biochem Biophys Res Commun. 2006;350(4):1006-1012.[23] Nakasa T, Ishikawa M, Shi M, et al. Acceleration of muscle regeneration by local injection of muscle-specific microRNAs in rat skeletal muscle injury model. J Cell Mol Med. 2010; 14(10):2495-2505.[24] Liu J, Luo XJ, Xiong AW, et al. MicroRNA-214 promotes myogenic differentiation by facilitating exit from mitosis via down-regulation of proto-oncogene N-ras. J Biol Chem. 2010;285(34):26599-26607.[25] Wang L, Zhao Y, Bao X, et al. LncRNA Dum interacts with Dnmts to regulate Dppa2 expression during myogenic differentiation and muscle regeneration. Cell Res. 2015; 25(3):335-350.[26] Miyahara Y, Nagaya N, Kataoka M, et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med. 2006;12(4):459-465.[27] Zhang X, Wang H, Ma X, et al. Preservation of the cardiac function in infarcted rat hearts by the transplantation of adipose-derived stem cells with injectable fibrin scaffolds. Exp Biol Med (Maywood). 2010;235(12):1505-1515.[28] Beitnes JO, Lunde K, Brinchmann JE, et al. Stem cells for cardiac repair in acute myocardial infarction. Expert Rev Cardiovasc Ther. 2011;9(8):1015-1025.[29] 陈犹白,陈聪慧,Qixu Zhang,等.脂肪干细胞成脂分化的研究进展[J].中国美容医学,2016,25(4):86-93.[30] 陈犹白,陈聪慧,Qixu Zhang,等.脂肪干细胞成骨分化的研究进展[J/CD].中华损伤与修复杂志:电子版,2016,11(2):126-134.[31] 陈犹白,郝永红,王岚,等.脂肪干细胞成脂分化的分子机制和信号通路[J].中国组织工程研究,2017,21(1):154-158.[32] Liu Y, Yan X, Sun Z, et al. Flk-1+ adipose-derived mesenchymal stem cells differentiate into skeletal muscle satellite cells and ameliorate muscular dystrophy in mdx mice. Stem Cells Dev. 2007;16(5):695-706.[33] Pinheiro CH, de Queiroz JC, Guimarães-Ferreira L, et al. Local injections of adipose-derived mesenchymal stem cells modulate inflammation and increase angiogenesis ameliorating the dystrophic phenotype in dystrophin-deficient skeletal muscle. Stem Cell Rev. 2012;8(2):363-374.[34] Winkler T, von Roth P, Radojewski P, et al. Immediate and delayed transplantation of mesenchymal stem cells improve muscle force after skeletal muscle injury in rats. J Tissue Eng Regen Med. 2012;6 Suppl 3:s60-67.[35] Wang L, Johnson JA, Chang DW, et al. Decellularized musculofascial extracellular matrix for tissue engineering. Biomaterials. 2013;34(11):2641-2654.[36] Zhang Q, Johnson JA, Dunne LW, et al. Decellularized skin/adipose tissue flap matrix for engineering vascularized composite soft tissue flaps. Acta Biomater. 2016;35:166-184.[37] 陈犹白,陈聪慧,Qixu Zhang,等.脂肪干细胞的分离、纯化和保存:研究进展和发展方向[J].中国组织工程研究,2016, 20(10): 1508-1520.[38] Muehlberg FL, Song YH, Krohn A, et al. Tissue-resident stem cells promote breast cancer growth and metastasis. Carcinogenesis. 2009;30(4):589-597.[39] Yu JM, Jun ES, Bae YC, et al. Mesenchymal stem cells derived from human adipose tissues favor tumor cell growth in vivo. Stem Cells Dev. 2008;17(3):463-473.[40] Galiè M, Konstantinidou G, Peroni D, et al. Mesenchymal stem cells share molecular signature with mesenchymal tumor cells and favor early tumor growth in syngeneic mice. Oncogene. 2008;27(18):2542-2551.[41] Kucerova L, Matuskova M, Hlubinova K, et al. Tumor cell behaviour modulation by mesenchymal stromal cells. Mol Cancer. 2010;9:129.[42] Prantl L, Muehlberg F, Navone NM, et al. Adipose tissue-derived stem cells promote prostate tumor growth. Prostate. 2010;70(15):1709-1715.[43] Eterno V, Zambelli A, Pavesi L, et al. Adipose-derived Mesenchymal Stem Cells (ASCs) may favour breast cancer recurrence via HGF/c-Met signaling. Oncotarget. 2014; 5(3):613-633.[44] Zhu Y, Sun Z, Han Q, et al. Human mesenchymal stem cells inhibit cancer cell proliferation by secreting DKK-1. Leukemia. 2009;23(5):925-933.[45] Cousin B, Ravet E, Poglio S, et al. Adult stromal cells derived from human adipose tissue provoke pancreatic cancer cell death both in vitro and in vivo. PLoS One. 2009;4(7):e6278.[46] Donahue HJ, Saunders MM, Li Z, et al. A potential role for gap junctions in breast cancer metastasis to bone. J Musculoskelet Neuronal Interact. 2003;3(2):156-161.[47] Bielli A, Scioli MG, Gentile P, et al. Adult adipose-derived stem cells and breast cancer: a controversial relationship. Springerplus. 2014;3:345.[48] Delay E, Garson S, Tousson G, et al. Fat injection to the breast: technique, results, and indications based on 880 procedures over 10 years. Aesthet Surg J. 2009;29(5): 360-376.[49] Petit JY, Botteri E, Lohsiriwat V, et al. Locoregional recurrence risk after lipofilling in breast cancer patients. Ann Oncol. 2012;23(3):582-588.[50] Rietjens M, De Lorenzi F, Rossetto F, et al. Safety of fat grafting in secondary breast reconstruction after cancer. J Plast Reconstr Aesthet Surg. 2011;64(4):477-483. |